Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-43,681
Closed -$2.14M 4195
2025
Q4
$2.14M Sell
43,681
-44,038
-50% -$1.85M 0.01% 1258
2025
Q3
$4.23M Buy
87,719
+75,004
+590% +$2.83M 0.02% 752
2025
Q2
$388K Buy
12,715
+547
+4% +$14.7K ﹤0.01% 1726
2025
Q1
$323K Sell
12,168
-14,770
-55% -$442K ﹤0.01% 1740
2024
Q4
$903K Buy
+26,938
New +$1.19M ﹤0.01% 1129
2024
Q2
Sell
-19,400
Closed -$256K 2579
2024
Q1
$256K Buy
+19,400
New +$207K ﹤0.01% 1643
2023
Q2
Sell
-104,146
Closed -$2.2M 2797
2023
Q1
$2.2M Buy
104,146
+59,623
+134% +$1.02M 0.03% 542
2022
Q4
$657K Buy
+44,523
New +$532K 0.01% 1234
2021
Q4
Sell
-56,773
Closed -$516K 3567
2021
Q3
$516K Sell
56,773
-5,161
-8% -$46.7K ﹤0.01% 1937
2021
Q2
$575K Buy
+61,934
New +$528K 0.01% 1632
2020
Q3
Sell
-35,480
Closed -$184K 2087
2020
Q2
$184K Buy
35,480
+21,221
+149% +$104K 0.01% 1169
2020
Q1
$54K Buy
+14,259
New +$84.5K ﹤0.01% 634

Other funds holding HROW

HRT Financial's HROW Position: Q1 2026 in Review

HRT Financial sold out of Harrow (HROW) in Q1 2026, closing a stake of 43,681 shares — an estimated $2.14M sold.

HRT Financial first reported a position in HROW in Q1 2020 and held it in 12 quarters. The position peaked at $4.23M in Q3 2025. 219 funds tracked by Wall St. Rank hold HROW as of Q1 2026.

  • HRT Financial reported no remaining Harrow position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 43,681 Harrow shares in Q1 2026, an estimated $2.14M.
  • HRT Financial first reported a position in Harrow in Q1 2020 and held it in 12 quarters.
  • HRT Financial's Harrow position peaked at $4.23M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Harrow as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.